4//SEC Filing
WATSON PHARMACEUTICALS INC 4
Accession 0001179110-07-013940
CIK 0000884629operating
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 12:18 PM ET
Size
7.8 KB
Accession
0001179110-07-013940
Insider Transaction Report
Form 4
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
- Award
Common Stock, par value $0.0033
2007-06-26+4,000→ 81,666 total
Holdings
- 692,085(indirect: By Trust)
Common Stock, par value $0.0033
- 1,004,218(indirect: By Partnership)
Common Stock, par value $0.0033
- 40,000(indirect: By Trust)
Common Stock, par value $0.0033
Footnotes (4)
- [F1]By Family Trust refers to the Hsia Family Trust, of which Dr. Hsia is a beneficial owner.
- [F2]By Partnership refers to the Hsia Interests, Ltd., of which Dr. Hsia is a general partner.
- [F3]The restricted stock was issued pursuant to the Second Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. and will vest 50% on March 11, 2009 and 50% on March 11, 2011.
- [F4]Includes shares of restricted stock issued pursuant to the Second Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
Documents
Issuer
WATSON PHARMACEUTICALS INC
CIK 0000884629
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0000884629
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 12:18 PM ET
- Size
- 7.8 KB